USFDA, Approves, Roches, Tecentriq, Atezolizumab, Adjuvant, Treatment, Nonsmall, Cell, LungCancer, Chemotherapy, Immunotherapy, IMpower010, monoclonal, antibody, protein, Global, Product, Development, PDL1, MOA, Efficacy, Dose, SideEffects